Hemenway Trust Hemenway Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.7M Buy
55,515
+1,191
+2% +$530K 1.91% 23
2025
Q1
$26.3M Buy
54,324
+4,911
+10% +$2.38M 2.14% 23
2024
Q4
$19.9M Buy
49,413
+9,294
+23% +$3.74M 1.61% 26
2024
Q3
$18.7M Buy
40,119
+11,682
+41% +$5.43M 1.48% 28
2024
Q2
$13.3M Buy
28,437
+12,919
+83% +$6.06M 1.14% 30
2024
Q1
$6.49M Buy
15,518
+10,835
+231% +$4.53M 0.56% 35
2023
Q4
$1.91M Buy
4,683
+917
+24% +$373K 0.18% 46
2023
Q3
$1.31M Buy
3,766
+40
+1% +$13.9K 0.14% 63
2023
Q2
$1.31M Buy
3,726
+185
+5% +$65.1K 0.13% 63
2023
Q1
$1.12M Sell
3,541
-5
-0.1% -$1.58K 0.12% 64
2022
Q4
$1.02M Buy
3,546
+125
+4% +$36.1K 0.11% 72
2022
Q3
$991K Buy
3,421
+890
+35% +$258K 0.12% 70
2022
Q2
$713K Buy
2,531
+1,110
+78% +$313K 0.08% 75
2022
Q1
$371K Hold
1,421
0.04% 103
2021
Q4
$312K Hold
1,421
0.03% 110
2021
Q3
$258K Buy
+1,421
New +$258K 0.03% 123